All In MedTech

Device Trial Radar · NCT03226808

Vivacit-E Post-market Follow-up Study

Post Market Clinical Follow-up Study of the Zimmer Vivacit-E Highly Crosslinked Polyethylene Liner Used With the Continuum Acetabular Shell

Last checked: Nov 19, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

245

Actual

Start

Oct 1, 2013

Primary completion

Apr 14, 2026

Study completion Apr 14, 2026

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Jul 24, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.

Conditions

  • Osteoarthritis
  • Avascular Necrosis of Bone of Hip
  • Post-traumatic; Arthrosis
  • Congenital Hip Dysplasia

Interventions

  • Vivacit-E LinerDevice

    All subjects enrolled will receive the Vivacit-E liner.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival of the study device; whether or not it is still implanted in the subjectTime frame: 10 years

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Denver Hip and Knee, Inc.

    Parker, Colorado

  • Department of Orthopaedics University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • OrthoCarolina Research Institute

    Charlotte, North Carolina

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.